Ameriprise
NRXP icon

Ameriprise’s NRX Pharmaceuticals NRXP Stock Holding History

Ameriprise’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Buy
+928,728
New +$3.07M ﹤0.01% 2737

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Ameriprise's NRXP Position: Q2 2026 in Review

Ameriprise opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 928,728 shares worth $3.8M. The stake represents ﹤0.01% of the portfolio and ranks #2737 among its holdings.

46 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Ameriprise held 928,728 shares of NRX Pharmaceuticals worth $3.8M as of Q2 2026.
  • NRX Pharmaceuticals was a new Ameriprise position in Q2 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2737 holding.
  • 46 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.